Methamphetamine use in young people
Investigator: Associate Professor Gillinder Bedi
Effective medication options are needed for methamphetamine use.
This study will identify young people who may be eligible to take part in one or more Orygen studies testing potential new medications for methamphetamine use
what does the study involve?
This study aims to identify young people who may be eligible to take part in Orygen studies testing potential new medications for methamphetamine use.
To work out if one of Orygen’s treatment studies is the right fit, participants will be required to attend appointments in Parkville They will complete a medical check-up including some tests (urine, blood and breath samples) and will be asked questions about their drug use, health, and mental health. This will take up to 3–4 hours and can be done over up to three visits.
These assessments will be used to see if participants are eligible to take part in one of Orygen’s clinical trials testing potential medications to manage methamphetamine use.
Participants may be reimbursed up to $525 for their time and for expenses they incur in order to take part in the study, such as parking or transport costs.
To be eligible participants must be aged between 15 and 35 years and:
- currently use methamphetamine (‘ice’ or ‘speed’)
Participation in the study is completely voluntary and Orygen researchers will ensure participants have all information about the study before they sign up.
Young people who are interested in participating in the study should complete the form below.
This study as been approved by Melbourne Health HREC (HREC/65565/MH-2020)